Friday, July 31, 2026

“KIDNAPPING? NEVER HEARD OF IT” The Cruel Gaslighting of Japan as Kim Yo-jong Spits on Bereaved Families

Kim Yo-jong rejects the idea of a North Korea-Japan summit, insisting Japan must change its outdated views before any dialogue can occur.

Targeting 2028: How POSCO’s Hydrogen Reduction Steelmaking Could Cut Carbon Emissions

The carbon neutrality initiative is gaining traction as industries invest in eco-friendly technologies amid the Middle East energy crisis.

How Korea’s Young Mathematicians Achieved 100% Medal Success at the 2023 International Math Olympiad

South Korean students excelled at the International Mathematical Olympiad, winning three gold medals and placing sixth overall.

News1

Author's Latest

LG Electronics First to Achieve NVIDIA Liquid Cooling Certification: What This Means for AI Data Centers

LG Electronics becomes the first South Korean firm to receive NVIDIA certification for its liquid cooling solution, enhancing AI data center strategies.

Pharos iBio Targets Global Licensing Deals, Expands U.S. and European Market Strategy

Pharos iBio aims to secure licensing deals and enhance its AI drug discovery platform for rare diseases, targeting global partnerships.

EuBiologics Registers EcML Adjuvant Platform With U.S. FDA Drug Master File

EuBiologics' EcML™ vaccine adjuvant platform has been registered with the FDA, enhancing immunogenicity and enabling global collaborations.

Celltrion Files for European Approval of Cosentyx Biosimilar, Targets $6.7 Billion Market

Celltrion has filed for European approval of its CT-P55 biosimilar for autoimmune diseases, aiming for early market entry and expansion.

Unlocking Precision Medicine: New Antibody Design Targets KRAS(G12D) in Cancer Cells

Researchers at KAIST developed an antibody targeting KRAS(G12D) mutation, revolutionizing cancer treatment with precise immunotherapy.

Eli Lilly’s Retatrutide: The Revolutionary Triple Hormone Treatment for Obesity – What You Need to Know

Eli Lilly's retatrutide shows promising results in Phase 3 trials, aiming for FDA approval for obesity and related conditions in 2027.

How Hanmi Pharmaceutical’s AI Platform is Revolutionizing Obesity Drug Development in 2026

Hanmi Pharmaceutical leverages AI for drug discovery, developing innovative obesity treatments and advancing to clinical trials.

Samsung Biologics’ Q2 Success: 30% Revenue Growth and Global Expansion Plans

Samsung Biologics exceeded Q2 market expectations due to stable performance from existing plants and new facilities in the U.S.

How Google’s AI Investment Boosts Demand for HBM and D-RAM: Insights for 2026

Big Tech's AI investments boost demand for semiconductors, benefiting Samsung and SK Hynix while promising growth in non-memory sectors.

Samsung Heavy Industries Strengthens U.S. Shipbuilding Ties with LNG Bunker Vessel Certification

Samsung Heavy Industries strengthens U.S. partnerships with agreements on LNG vessels, AI research, and training initiatives at KUSPC.

Interview | “Suicides Are Falling Overall? Not Among Young People—We Need Policies That Look 20 Years Ahead”

The government's suicide prevention efforts show a decline in overall rates, but youth suicides remain a critical issue needing attention.

Blood Test Alone May Predict Chemotherapy Response and Prognosis in Lymphoma Patients

South Korean researchers discover a mechanism reducing rituximab's effectiveness in DLBCL and propose a predictive blood biomarker.

‘Dream Weight-Loss Drug’ Wegovy May Also Protect Brain Health by Reducing Risk of Adult-Onset Seizures

Semaglutide may reduce adult-onset seizure risk by 56%, suggesting a link between metabolic treatment and brain health.

LG Energy Solution Expands Battery Patent Fight, Files U.S. ITC Complaint Against China’s EVE Energy

LG Energy Solution files a patent complaint against EVE Energy, expanding its enforcement to cylindrical battery technologies in the U.S.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.